PharVision Advisers’s Quantum Computing Inc QUBT Stock Holding History

PharVision Advisers’s Portfolio QUBT Stock Details QUBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,399	Closed	-$171K	–	398
2025 Q1	$171K	Buy	+21,399	New	+$188K	0.24%	218

Other funds holding QUBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

PharVision Advisers's QUBT Position: Q2 2025 in Review

PharVision Advisers sold out of Quantum Computing Inc (QUBT) in Q2 2025, closing a stake of 21,399 shares — an estimated $171K sold.

PharVision Advisers first reported a position in QUBT in Q1 2025 and held it in 1 quarter. The position peaked at $171K in Q1 2025. 222 funds tracked by Wall St. Rank hold QUBT as of Q2 2025.

PharVision Advisers reported no remaining Quantum Computing Inc position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 21,399 Quantum Computing Inc shares in Q2 2025, an estimated $171K.
PharVision Advisers first reported a position in Quantum Computing Inc in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Quantum Computing Inc position peaked at $171K in Q1 2025.
222 funds tracked by Wall St. Rank held Quantum Computing Inc as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.